Entecavir CAS 142217-69-4 API Factory Quality Anti-HBV
Manufacturer Supple cum High puritate et stabulo Quality
Nomen chemicum: Entecavir
CAS: 142217-69-4
Medicamentum antivirale in curatione Hepatitis B infectio
API High Quality, Commercial Production
Nomen chemicum | Entecavir |
Synonyma | 2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-unum |
CAS Number | 142217-69-4 |
CATTUS Number | RF-API80 |
Stock Status | In Stock, Productio Ascendite usque ad Centum chiliogrammata |
Formulae hypotheticae | C12H15N5O3 |
M. Pondus | 277.28 |
Liquescens punctum | 249.0~ 252.0℃ |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Crystallina pulveris alba |
Lepidium sativum IR | Effusio infraed spectri specimen experimenti concordare debet cum signo referente |
Lepidium sativum HPLC | Retentio tempus specimen probati correspondet relationis vexillum |
pH | 5.5~7.5 |
Imprimis Rotatione Optica | +24.0°-+28.0° (DMF: MeOH=1:1 C=1%) |
Substantiae cognatae | |
Totalis immunditias | ≤0.30% |
Maximum Impuritas | ≤0.10% |
Enantiomer | ≤0.20% |
RELICTUM Solvents | |
Methanol | ≤0.30% |
Dichloromethane | ≤0.06% |
n-Hexane | ≤0.029% |
Tetrahydrofuran | ≤0.072% |
N,N-Dimethylformamide | ≤0.088% |
Toluene | ≤0.089% |
Aqua Content | 5.8%~6.5% |
Residere in Ignition | ≤0.10% |
Metalla gravis | ≤20ppm |
Assay | 98.0%~ 102.0% (C12H15N5O3 calculi anhydroi basis) |
Magnitudo particula | D90: ≤100µm |
Test Standard | Enterprise Standard |
Consuetudinem | API, Medicamentum Antiviralis in Hepatitis B Infectionis curatione adhibitum |
sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.
Entecavir nova est generatio guanini nucleosidi analogorum oralis medicina curatio Hepatitis B Virus (HBV) infectio, maxime pro curatione aegrorum adultorum cum actione replicatione virali et serum transaminatis continuatum ad augendum, seu iecoris textus pro activitate pathologica longi hepatitis B nunc est virus velocissimum et potentissimum, mutatio rate infima analogorum nucleosiderum.Data ostendunt diversam aegros cum hepatitis longis B, incluso nucleoside rustica et nucleoside curata et aegros iecoris cirrhosis, bene entecavir tabulas in curatione moderari posse morbum celeriter et facilem curationem rei finis attingere, scilicet hepatitis B virus immensum;per adhaesionem curationi, magna portio aegrorum ad satisfaciendum curationis finem perveniri potest, nempe e serologia antigene conversionis, quidam aegros etiam attingere possunt specimen pro curatione finis, nempe superficies negativae antigenis.